COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $66 | -100.0% | 2,851 | -92.9% | 0.00% | -100.0% |
| Q3 2022 | $643,000 | +16.1% | 40,163 | +28.3% | 0.00% | 0.0% |
| Q2 2022 | $554,000 | +64.9% | 31,305 | +89.6% | 0.00% | – |
| Q1 2022 | $336,000 | -14.1% | 16,508 | -21.1% | 0.00% | – |
| Q4 2021 | $391,000 | +492.4% | 20,935 | +644.8% | 0.00% | – |
| Q2 2021 | $66,000 | -73.4% | 2,811 | -73.2% | 0.00% | – |
| Q1 2021 | $248,000 | -65.7% | 10,475 | -71.0% | 0.00% | -100.0% |
| Q4 2020 | $723,000 | +8.1% | 36,121 | +12.3% | 0.00% | 0.0% |
| Q3 2020 | $669,000 | -19.3% | 32,175 | -32.1% | 0.00% | 0.0% |
| Q2 2020 | $829,000 | +314.5% | 47,411 | +464.1% | 0.00% | – |
| Q2 2018 | $200,000 | -6.5% | 8,405 | 0.0% | 0.00% | – |
| Q1 2018 | $214,000 | – | 8,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |